Modulation of vitamin D synthesis and catabolism in colorectal mucosa: A new target for cancer prevention

Anticancer Research

Volumn 29, Issue 9, 2009, Pages 3705-3712

  Cross, Heide S ^a   Nittke, Thomas ^a   Peterlik, Meinrad ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

1,25dihydroxyvitamin D3; Calcium; Colon tumor prevention; Epigenetic regulation; Estrogen; Extrarenal vitamin D synthesis; Review; Vitamin D hydroxylases

Indexed keywords

CALCIDIOL 1 MONOOXYGENASE; CALCIFEDIOL; FOLIC ACID; PHYTOESTROGEN; VITAMIN D; VITAMIN D RECEPTOR;

CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER PREVENTION; CATABOLISM; COLON MUCOSA; COLORECTAL CANCER; CONFERENCE PAPER; DISEASE ASSOCIATION; ESTROGEN ACTIVITY; HUMAN; NUTRIENT; PRIORITY JOURNAL; RECTUM MUCOSA; TUMOR GROWTH; VITAMIN D METABOLISM; VITAMIN INTAKE;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; COLON; COLORECTAL NEOPLASMS; DIET; EPIGENESIS, GENETIC; HUMANS; INTESTINAL MUCOSA; KIDNEY; RECTUM; SIGNAL TRANSDUCTION; STEROID HYDROXYLASES; VITAMIN D;

EID: 68549117143     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (54)

1. Grant WB: An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer 94: 1867-1875, 2002.
2. Garland CF and Garland FC: Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 9: 227-231, 1980.
3. Garland FC, Garland CF, Gorham ED and Young JF: Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med 19: 614-622, 1990.
4. Schwartz GG and Hulka BS: Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). Anticancer Res 10: 1307-1311, 1990.
5. Calvo MS, Whiting SJ and Barton CN: Vitamin D intake: a global perspective of current status. J Nutr 135: 310-316, 2005. (Pubitemid 40194498)
6. Prosser DE and Jones G: Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem Sci 29: 664-673, 2004.
7. 3-1α-hydroxylase activity and regulation of side-chain metabolism. J Steroid Biochem Mol Biol 62: 21-28, 1997. (Pubitemid 27462746)
8. Holt PR, Arber N, Halmos B, Forde K, Kissileff H, McGlynn KA, Moss SF, Kurihara N, Fan K, Yang K and Lipkin M: Colonic epithelial cell proliferation decreases with increasing levels of serum 25-hydroxy vitamin D. Cancer Epidemiol Biomarkers Prev 11: 113-119, 2002. (Pubitemid 34118320)
9. Rowling MJ, Kemmis CM, Taffany DA and Welsh J: Megalin-mediated endocytosis of vitamin D-binding protein correlates with 25- hydroxycholecalciferol actions in human mammary cells. J Nutr 136: 2754-2759, 2006.
10. 3 down-regulates CYP27B1 and induces CYP24A1 in colon cells. Mol Cell Endocrinol 263: 55-64, 2007. (Pubitemid 44828231)
11. Cross HS, Bises G, Lechner D, Manhardt T and Kallay E: The vitamin D endocrine system of the gut - its possible role in colorectal cancer prevention. J Steroid Biochem Mol Biol 97: 121-128, 2005. (Pubitemid 41546221)
12. Deeb KK, Trump DL and Johnson CS: Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 7: 684-700, 2007.
13. Zinser GM, Sundberg JP and Welsh J: Vitamin D(3) receptor ablation sensitizes skin to chemically induced tumorigenesis. Carcinogenesis 23: 2103-2109, 2002.
14. Kallay E, Pietschmann P, Toyokuni S, Bajna E, Hahn P, Mazzucco K, Bieglmayer C, Kato S and Cross HS: Characterization of a vitamin D receptor knockout mouse as a model of colorectal hyperproliferation and DNA damage. Carcinogenesis 22: 1429-1435, 2001. (Pubitemid 32898700)
15. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, Dominguez CE and Jurutka PW: The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 13: 325-349, 1998.
16. Palmer HG, Gonzalez-Sancho JM, Espada J, Berciano MT, Puig I, Baulida J, Quintanilla M, Cano A, de Herreros AG, Lafarga M and Munoz A: Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol 154: 369-387, 2001. (Pubitemid 34286147)
17. Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM and Hewison M: Extrarenal expression of 25-hydroxyvitamin D(3)-1α-hydroxylase. J Clin Endocrinol Metab 86: 888-894, 2001.
18. 3-1α-hydroxylase expression in normal and malignant human colon. J Histochem Cytochem 52: 985-989, 2004. (Pubitemid 38857163)
19. Cross HS, Bareis P, Hofer H, Bischof MG, Bajna E, Kriwanek S, Bonner E and Peterlik M: 25-Hydroxyvitamin D(3)-1alpha-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis. Steroids 66: 287-292, 2001. (Pubitemid 32140906)
20. 3 is mediated by mutual modulation of receptor expression. Eur J Cancer 34: 2119-2125, 1998. (Pubitemid 28546952)
21. Sheinin Y, Kaserer K, Wrba F, Wenzl E, Kriwanek S, Peterlik M and Cross HS: In situ mRNA hybridization analysis and immunolocalization of the vitamin D receptor in normal and carcinomatous human colonic mucosa: relation to epidermal growth factor receptor expression. Virchows Arch 437: 501-507, 2000.
22. Bareis P, Kallay E, Bischof MG, Bises G, Hofer H, Potzi C, Manhardt T, Bland R and Cross HS: Clonal differences in expression of 25-hydroxyvitamin D(3)-1α- hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1α,25-dihydroxyvitamin D(3). Exp Cell Res 276: 320-327, 2002.
23. Calle EE, Miracle-McMahill HL, Thun MJ and Heath CW Jr: Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women. J Natl Cancer Inst 87: 517-523, 1995.
24. DeCosse JJ, Ngoi SS, Jacobson JS and Cennerazzo WJ: Gender and colorectal cancer. Eur J Cancer Prev 2: 105-115, 1993.
25. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E and Thun MJ: Cancer statistics, 2003. CA Cancer J Clin 53: 5-26, 2003.
26. Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, Hubbell FA, Ascensao J, Rodabough RJ, Rosenberg CA, Taylor VM, Harris R, Chen C, Adams-Campbell LL and White E: Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med 350: 991-1004, 2004. (Pubitemid 38269276)
27. Foley EF, Jazaeri AA, Shupnik MA, Jazaeri O and Rice LW: Selective loss of estrogen receptor β in malignant human colon. Cancer Res 60: 245-248, 2000. (Pubitemid 30070743)
28. Nelson LR and Bulun SE: Estrogen production and action. J Am Acad Dermatol 45: S116-124, 2001.
29. Lindberg MK, Moverare S, Skrtic S, Gao H, Dahlman-Wright K, Gustafsson JA and Ohlsson C: Estrogen receptor (ER)-β reduces ERβ-regulated gene transcription, supporting a 'ying yang' relationship between ERα and ERα in mice. Mol Endocrinol 17: 203-208, 2003.
30. Campbell-Thompson M, Lynch IJ and Bhardwaj B: Expression of estrogen receptor (ER) subtypes and ERα isoforms in colon cancer. Cancer Res 61: 632-640, 2001. (Pubitemid 32128626)
31. Liel Y, Shany S, Smirnoff P and Schwartz B: Estrogen increases 1,25-dihydroxyvitamin D receptors expression and bioresponse in the rat duodenal mucosa. Endocrinology 140: 280-285, 1999. (Pubitemid 29011170)
32. Lechner D, Bajna E, Adlercreutz H and Cross HS: Genistein and 17β-estradiol, but not equol, regulate vitamin D synthesis in human colon and breast cancer cells. Anticancer Res 26: 2597-2603, 2006. (Pubitemid 44155540)
33. Protiva P, Cross HS, Hopkins ME, Kallay E, Bises G, Dreyhaupt E, Augenlicht L, Lipkin M, Lesser M, Livote E and Holt PR: Chemoprevention of colorectal neoplasia by estrogen: potential role of vitamin D activity. Cancer Prev Res (Phila Pa) 22: 43-51, 2009.
34. Hori J, Hiraoka S, Kato J, Harada K, Kuwaki K, Fujita H, Toyooka S and Yamamoto K: Age-related methylation in normal colon mucosa differs between the proximal and distal colon in patients who underwent colonoscopy. Clin Biochem 41: 1440-1448, 2008.
35. Barault L, Charon-Barra C, Jooste V, de la Vega MF, Martin L, Roignot P, Rat P, Bouvier AM, Laurent-Puig P, Faiyre J, Chapusot C and Piard F: Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases. Cancer Res 68: 8541-8546, 2008.
36. 3-induced DNA methylation suppresses the human CYP27B1 gene. Mol Cell Endocrinol 265-266: 168-173, 2007. (Pubitemid 46273961)
37. Smirnoff P, Liel Y, Gnainsky J, Shany S and Schwartz B: The protective effect of estrogen against chemically induced murine colon carcinogenesis is associated with decreased CpG island methylation and increased mRNA and protein expression of the colonic vitamin D receptor. Oncol Res 11: 255-264, 1999.
38. Cross H, Bises G, Lechner D, Manhardt T and Kallay E: The vitamin D endocrine system of the gut - its possible role in colorectal cancer prevention. J Steroid Biochem Mol Biol 97: 121-128, 2005. (Pubitemid 41546221)
39. Lechner D, Kallay E and Cross HS: 1α,25-Dihydroxyvitamin D(3) down-regulates CYP27B1 and induces CYP24A1 in colon cells. Mol Cell Endocrinol 263: 55-64, 2007. (Pubitemid 44828231)
40. Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ and Willett WC: Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 98: 451-459, 2006.
41. Grau MV, Baron JA, Sandler RS, Haile RW, Beach ML, Church TR and Heber D: Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst 95: 1765-1771, 2003. (Pubitemid 38008899)
42. Kallay E, Bises G, Bajna E, Bieglmayer C, Gerdenitsch W, Steffan I, Kato S, Armbrecht HJ and Cross HS: Colon-specific regulation of vitamin D hydroxylases - a possible approach for tumor prevention. Carcinogenesis 26: 1581-1589, 2005. (Pubitemid 41236051)
43. Nehring JA, Zierold C and DeLuca HF: Lithocholic acid can carry out in vivo functions of vitamin D. Proc Natl Acad Sci USA 104: 10006-10009, 2007. (Pubitemid 47175253)
44. Cross HS: Extrarenal vitamin D hydroxylase expression and activity in normal and malignant cells: modification of expression by epigenetic mechanisms and dietary substances. Nutr Rev 65: S108-112, 2007.
45. Cross HS, Kallay E, Farhan H, Weiland T and Manhardt T: Regulation of extrarenal vitamin D metabolism as a tool for colon and prostate cancer prevention. Recent Results Cancer Res 164: 413-425, 2003.
46. Cross HS, Kallay E, Lechner D, Gerdenitsch W, Adlercreutz H and Armbrecht HJ: Phytoestrogens and vitamin D metabolism: a new concept for the prevention and therapy of colorectal, prostate, and mammary carcinomas. J Nutr 134: 1207S-1212S, 2004. (Pubitemid 38619965)
47. Bises G, Bajna E, Manhardt T, Gerdenitsch W, Kallay E and Cross HS: Gender-specific modulation of markers for premalignancy by nutritional soy and calcium in the mouse colon. J Nutr 137: 211S-215S, 2007. (Pubitemid 46052883)
48. Pfeiffer CM, Johnson CL, Jain RB, Yetley EA, Picciano MF, Rader JI, Fisher KD, Mulinare J and Osterloh JD: Trends in blood folate and vitamin B-12 concentrations in the United States, 1988 2004. Am J Clin Nutr 86: 718-727, 2007.
49. Keyes MK, Jang H, Mason JB, Liu Z, Crott JW, Smith DE, Friso S and Choi SW: Older age and dietary folate are determinants of genomic and p16-specific DNA methylation in mouse colon. J Nutr 137: 1713-1717, 2007. (Pubitemid 47037696)
50. Choi SW and Mason JB: Folate and carcinogenesis: an integrated scheme. J Nutr 130: 129-132, 2000.
51. Giovannucci E, Stampfer MJ, Colditz GA, Hunter DJ, Fuchs C, Rosner BA, Speizer FE and Willett WC: Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Ann Intern Med 129: 517-524, 1998. (Pubitemid 28460290)
52. Newmark HL and Lipkin M: Calcium, vitamin D, and colon cancer. Cancer Res 52: 2067s-2070s, 1992.
53. Newmark HL, Yang K, Lipkin M, Kopelovich L, Liu Y, Fan K and Shinozaki H: A Western-style diet induces benign and malignant neoplasms in the colon of normal C57B1/6 mice. Carcinogenesis 22: 1871-1875, 2001.
54. Cross HS, Lipkin M and Kallay E: Nutrients regulate the colonic vitamin D system in mice: relevance for human colon malignancy. J Nutr 136: 561-564, 2006. (Pubitemid 43363735)